Conditions: Lung Cancer, Nonsmall Cell; Thyroid Cancer; Solid Tumor
Intervention: Drug: BLU-667
Sponsor: Blueprint Medicines Corporation
Not yet recruiting - verified January 2017
http://ift.tt/2kmTky3
http://ift.tt/2kcBqMb
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Background Mindfulness based stress reduction (MBSR) is increasingly being used to improve outcomes such as stress and depression...
-
The treatment and outcome analysis of primary squamous cell carcinoma of the thyroid. : Related Articles The treatment and outcome...
-
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182, Medicine by Alexandros G. Sfakianakis,...
-
Objective: We compare the effect of daily versus weekly levothyroxine (LT4) replacement on thyroid function test (TFT) in hypothyroid patie...
-
Abstract Background Chronic graft-versus-host disease (GVHD) appears several months following allogenic hematopoietic stem cell transplant...
-
Publication date: May 2017 Source: Neuroimaging Clinics of North America, Volume 27, Issue 2 http://ift.tt/2pfyuQ5 http://ift.tt/2...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου